CRI's new website that seeks to engage, educate, and empower patients and their loved ones to learn more about cancer immunotherapy as a treatment option across numerous tumor types.
Cancer patients, donors, scientists, and other supporters all stand behind the Cancer Research Institute. Read their stories and learn about what motivates each of us to keep fighting against cancer.
Join us on June 25, 2016, for a one-day, multi-distance “Answer to Cancer” cycling event throughout New York's Lower Hudson Valley and sponsored by Bristol-Myers Squibb.
We gratefully accept donations made in memory or in honor of a loved one. Your gift will be acknowledged to whomever you specify.
Hosted by CRI, EATI, CIMT, and AACR, register today for "Translating Science into Survival," on September 25-28, 2016, in New York City.
Curious about the latest developments in cancer immunotherapy research? Listen in as leading scientists discuss immune-based treatments across numerous cancer types in our free "Cancer Immunotherapy and You" webinar series.
When the Cancer Research Institute was founded in 1953, we knew then that immune-based treatments would transform cancer medicine. In more than six decades since, we've made numerous groundbreaking discoveries that have given more patients new hope today.
Welcome to the Cancer Research Institute blog. Here we share the latest updates on the field of cancer immunotherapy from CRI, including scientific breakthroughs, news stories, and program announcements. We invite your comments and encourage you to share these stories with your friends.
You can receive notifications of new posts by subscribing to our blog. Just click the RSS icon in the upper right corner.
April 20, 2016
Anti-PD-1 blockade and two other types of immunotherapy effective in treating multiple tumor types.
community fundraising, young philanthropists
Xueling Wu, a CRI postdoctoral fellow from 2003-2006, has recently been appointed an assistant professor at the Aaron Diamond AIDS Research Center at The Rockefeller University.
AIDS, fellows, vaccine
A breakthrough new treatment that genetically modifies immune cells in cancer patients is showing tremendous promise in helping adults with an aggressive form of leukemia.
gene therapy, leukemia, T cell therapy
The New York Observer named Cancer Research Institute Young Philanthropists Council chair Alexis Feldman as one of its "20 Under 40" Top Young Philanthropists in its 2013 annual philanthropy supplement.
in the news, young philanthropists
Mark Sundrud, a former CRI Irvington Postdoctoral Fellow (2006-2009) has been appointed assistant professor in the Department of Cancer Biology at The Scripps Research Institute.
Cancer Research Institute has launched a new website that features expert information on the latest breakthroughs in cancer immunotherapy, helpful patient information, videos, infographics, and more.
The Winter 2013 issue of The Researcher, CRI's print newsletter, is now available online.
11 year old Kate Bockholt watched her mother battle (and beat) cancer. Now she wants to help fund research so others don't have to suffer. She created a necklace that inspires hope and helps to save lives.
The Cancer Research Institute 2012 Annual Report is now available for download.
annual report, innovation, progress
Immunotherapies for cancer are transforming patient care, and stories of survival and hope are becoming more frequent, thanks to advances in cancer research.
immunotherapy, patients, survival